C07F 9/60
Quinoline or hydrogenated quinoline ring systems
C07F9/60 (Quinoline or hydrogenated quinoline ring systems) appears on 203 US grants and 153 published applications in this corpus.
Search patents in C07F- Granted patents
- 203
- Published applications
- 153
- Assignees
- 140
- Inventors
- 671
- Latest grant
- 26 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 9 | 0 |
| 1999 | 7 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 1 |
| 2002 | 7 | 3 |
| 2003 | 4 | 6 |
| 2004 | 4 | 8 |
| 2005 | 4 | 8 |
| 2006 | 7 | 4 |
| 2007 | 2 | 3 |
| 2008 | 5 | 3 |
| 2009 | 3 | 7 |
| 2010 | 2 | 6 |
| 2011 | 4 | 4 |
| 2012 | 5 | 13 |
| 2013 | 10 | 18 |
| 2014 | 9 | 25 |
| 2015 | 14 | 8 |
| 2016 | 5 | 4 |
| 2017 | 3 | 2 |
| 2018 | 3 | 6 |
| 2019 | 2 | 2 |
| 2020 | 6 | 1 |
| 2021 | 3 | 2 |
| 2022 | 0 | 2 |
| 2023 | 0 | 5 |
| 2024 | 1 | 1 |
| 2025 | 0 | 6 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nitroxoline prodrug and use thereof26 Nov 2024US 12,152,048 B2Jiangsu Yahong Meditech Co., Ltd.
- Organic electron transport material and organic electroluminescent element using same13 Jul 2021US 11,063,223 B2Dyden Corporation
- Drug targets of delayed aging and human brain diseases27 Apr 2021US 10,987,367 B2Texas Tech University System
- Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates23 Feb 2021US 10,927,135 B2The Board of Regents of the Nevada System of Higher Education On Behalf of the University of Nevada, Las Vegas
- Organic electronic device29 Dec 2020US 10,879,473 B2Novaled GmbH
- Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof10 Sep 2026US 2026/0263431 A1Allianthera Boston Inc.
- Polycyclic thyroid hormone beta receptor agonist and use thereof20 Aug 2026US 2026/0242350 A1Cascade Pharmaceuticals, Inc.
- Modulator for promoting binding of butyrophilin 3a1/2a123 Jul 2026US 2026/0207637 A1Unicet Biotech Co. LLC.
- Novel thiol reductant, method and use thereof29 Jan 2026US 2026/0027227 A1Suzhou Bioreinno Biotechnology Limited Company
- Spirocyclohexane derivatives, pharmaceutical compositions containing them and their uses as anti-apoptotic inhibitors1 Jan 2026US 2026/0001846 A1Les Laboratoires Servier
Most cited
By later US patents
- Substituted aminomethylphosphines, compositions and coordination complexes of same, their synthesis and processes using same82US 6,043,363 ASymyx Technologies, Inc. · 2000
- Substituted aminomethylphosphines, coordination complexes of aminomethylphosphines and their synthesis77US 6,034,240 ASymyx Technologies, Inc. · 2000
- Phosphonic acid derivatives65US 5,719,303 AEisai Co., Ltd. · 1998
- Pyridine anchors for HMG-CoA reductase inhibitors54US 5,506,219 AE. R. Squibb & Sons, Inc. · 1996
- Quinoline and pyridine anchors for HMG-CoA reductase inhibitors48US 5,691,322 AE. R. Squibb & Sons, Inc. · 1997